Skyrocketing Drug Prices: Year One of the Trump Administration

Thumbnail Image
Serial Number
Levin Center Identifier
Document Date
Report Length
23 pages
Policy Agendas Project Major Code
Policy Agendas Project Minor Code
Additional, Minority, Dissenting Views
Found Using Methodology
Idependent Author(s)
Brief Executive Summary
At the request of Ranking Member Representative Elijah E. Cummings, the Democratic staff of the House Committee on Oversight and Government Reform has compiled this report to assess the status of drug prices after the first year of Donald Trump's Presidency. Investigative findings are presented that detail prescription drug price data in three ways based on analysis of changes in Average Wholesale Prices (AWP) from December 31, 2016, to March 1, 2018.
Press Releases and Contextual Information
Related Hearings
Authors–Congress Members
Authors–Staff Members
Authors–Ex Officio Members
Authors–Additional, Minority, Dissenting Views